衰弱急性冠脉综合征患者的血运重建:回顾性纵向研究
该研究基于英格兰2010–2015年ACS住院患者数据,用医院衰弱风险评分定义衰弱,以地区血运重建差异为工具变量进行因果推断。工具变量分析提示,中、高衰弱风险患者血运重建后1年心血管死亡绝对降幅高于低衰弱风险者,且与短期和长期生存获益相关。
要点
- ACS患者中衰弱常见,中、高衰弱风险者血运重建可能性更低而死亡风险更高。
- 工具变量分析提示中、高衰弱风险患者血运重建后1年心血管死亡绝对降幅更大。
- 校正已测和未测混杂后,血运重建与中、高衰弱风险者短期和长期生存获益相关。
核心结论
- 衰弱在ACS患者中常见,心血管原因为主要死亡方式。
- 校正已测和未测混杂后,血运重建与中、高衰弱风险ACS患者短期和长期生存获益相关。
研究设计与样本
- 回顾性纵向研究,数据来自英格兰2010–2015年医院 Episode Statistics 并链接国家统计局死亡数据。
- 采用工具变量分析,以地区血运重建差异估计血运重建对5年内心血管死亡的平均治疗效应。
主要发现
- 与低衰弱风险相比,中、高衰弱风险与超声心动图、侵入性血管造影或血运重建可能性降低相关,并与死亡和主要不良心血管事件可能性增加相关。
- 5年心血管死亡在低、中、高衰弱风险者中分别为78.6%、77.3%和75.7%。
- 工具变量分析提示,与低衰弱风险相比,中、高衰弱风险患者血运重建后1年心血管死亡绝对降幅更高。
临床怎么用
- 对ACS患者应评估衰弱风险,中、高衰弱风险者不应仅因衰弱而排除血运重建评估。
- 中、高衰弱风险ACS患者血运重建可能与短期和长期生存获益相关,临床决策需综合个体情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Frailty is increasingly prevalent in people presenting with acute coronary syndrome (ACS). This high-risk group is typically excluded from trials of interventions in ACS, and there is uncertainty about the risks and benefits of invasive management. METHODS: Patients with an ACS diagnosis between 2010 and 2015 in England were identified from Hospital Episode Statistics, with linked Office for National Statistics mortality data. Frailty was defined by the Hospital Frailty Risk Score. Causal inference analysis used regional variation in revascularization as an instrumental variable to estimate average treatment effects of revascularization on cardiovascular mortality up to 5 years in people presenting with ACS and low-, intermediate-, or high-risk frailty. RESULTS: The analysis included 565 378 ACS patients, of whom 11.6% (n = 65 522) were at intermediate risk and 4.7% (n = 26 504) were at high risk of frailty. Intermediate and high frailty risks were associated with reduced likelihood of echocardiography, invasive angiography, or revascularization and increased likelihood of mortality and major adverse cardiovascular events compared with low frailty risk. Cardiovascular death at 5 years was 78.6%, 77.3%, and 75.7% in people at low, intermediate, and high frailty risk, respectively. Instrumental variable analysis suggested that revascularization resulted in a higher absolute reduction in cardiovascular mortality in high and intermediate frail risk patients compared with low risk at 1-year post-ACS. CONCLUSIONS: Frailty is common in people presenting with ACS, where cardiovascular causes are the principal mode of death. Revascularization is associated with short- and long-term survival benefits in people at intermediate and high risk of frailty after adjustment for measured and unmeasured confounders.
引用
- Roman, Miksza, Lai, et al. Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study. Eur Heart J. 2025. PMID: 39548842. doi:10.1093/eurheartj/ehae755
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。